This Viewpoint from the US Preventive Services Task Force (USPSTF) introduces their 2017 draft recommendation statement on screening for prostate cancer, explains how it differs from their 2012 recommendation, and invites public comment.
No takes yet. Share an insight, caveat, or question.
Bibbins‐Domingo et al. (2017) studied this question.